Skip to main content

Table 1 Patient characteristics

From: [68Ga]Ga-PSMA-11 PET before and after initial long-term androgen deprivation in patients with newly diagnosed prostate cancer: a retrospective single-center study

Characteristics Results
Age [years], median, mean, range 70, 69, 57–80
Time between ADT initiation and second [68Ga]Ga-PSMA-PET [days], median, mean, range 155, 158, 61–289
PSA value at [68Ga]Ga-PSMA-PET (T1), median, mean, range [ng/ml] 29.1, 39.0, 2.5–107.0
PSA value at [68Ga]Ga-PSMA-PET (T2), median, mean, range [ng/ml] 0.71, 1.24, 0.05–4.91
Lesions T1 versus T2
Prostate tumor [n: patients; n: lesions] 21 versus 17; 24 versus 18
Lymph node metastases [n: patients; n: lesions] 16 versus 10; 56 versus 20
Bone metastases [n: patients; n: lesions] 14 versus 10; 27 versus 12a
Sum [n: lesions] 107 versus 50a
PSMA derived tumor volume (PSMA-TV) of all lesions at T1, sum [ml] 505.69
PSMA derived tumor volume (PSMA-TV) of all lesions T2, sum [ml], (% of T1) 121.51 (24.0%)
Total lesion PSMA (TL-PSMA) of all lesions at T1, sum [ml] 9016.32
Total lesion PSMA (TL-PSMA) of all lesions at T2, sum [ml], (% of T1) 1256.91 (13.9%)
  1. aTwo of these were new in T2